These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6223410)

  • 1. Identity of PL3A and SB1.
    Termijtelen A; Shaw S; van Rood JJ
    Tissue Antigens; 1983 May; 21(5):400-1. PubMed ID: 6223410
    [No Abstract]   [Full Text] [Related]  

  • 2. [Genetic organization and polymorphism of the HLA-D region].
    Guilherme L; Colombani M; Sansonetti N; Colombani J
    Ann Immunol (Paris); 1983; 134C(1):3-24. PubMed ID: 6190429
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of four SB antigens by cloned cells. Population studies of Norwegians.
    Moen T; Bratlie A; Kiss E; Bruserud O; Thorsby E
    Tissue Antigens; 1983 Oct; 22(4):298-309. PubMed ID: 6228036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of unrelated bone marrow donors: does the current procedure warrant complete MHC class II identity?
    Eiermann TH; Ballas M; Fakler J; Müller C; Wölpl A; Goldmann SF
    Beitr Infusionsther; 1992; 30():320-3. PubMed ID: 1284725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-cell alloantigen matching by the lymphocyte insulin receptor assay.
    Helderman JH; Garovoy MR; Strom TB
    Transplant Proc; 1981 Mar; 13(1 Pt 2):1042-3. PubMed ID: 6455812
    [No Abstract]   [Full Text] [Related]  

  • 6. Detection by three cellular immunological techniques of the antigenic determinants of the Ly-Li system, expressed on human B lymphocytes.
    Sasportes M; Mawas C; Crosier P; Charmot D; Legrand L; Dausset J
    Scand J Immunol; 1977; 6(5):507-10. PubMed ID: 70070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics HLA: the major human histocompatibility system.
    Bodmer WF; Jones EA; Barnstable CJ; Bodmer JG
    Proc R Soc Lond B Biol Sci; 1978 Jun; 202(1146):93-116. PubMed ID: 27817
    [No Abstract]   [Full Text] [Related]  

  • 8. Overview. The major histocompatibility system of the rat.
    Günther E; Stark O
    Transplant Proc; 1979 Sep; 11(3):1550-3. PubMed ID: 92081
    [No Abstract]   [Full Text] [Related]  

  • 9. Primed lymphocyte typing in man.
    Morling N
    Dan Med Bull; 1983 May; 30(3):158-76. PubMed ID: 6190618
    [No Abstract]   [Full Text] [Related]  

  • 10. Production and isolation of helper and suppressor factors.
    Altman A; Katz DH
    J Immunol Methods; 1980; 38(1-2):9-41. PubMed ID: 6161194
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of primary MLC of the non HLA-D/DR determinant PL3A.
    Termijtelen A; van Rood JJ
    Tissue Antigens; 1981 Jan; 17(1):57-63. PubMed ID: 6166084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variable MLC stimulatory capacity of neoplastic B and non-B/non-T lymphocytes expressing HLA-DR antigens.
    Bom-van Noorloos AA; Schreuder I; de Groot-Swings G; Ubels-Postma J; von dem Borne AE; Melief CJ
    Tissue Antigens; 1982 Nov; 20(5):352-63. PubMed ID: 6218653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human major histocompatibility system.
    Thorsby E
    Transplant Rev; 1974; 18():51-129. PubMed ID: 4141523
    [No Abstract]   [Full Text] [Related]  

  • 14. Highlights of the workshop on primary immunodeficiencies: where have we been - where are we going?
    Good RA
    Birth Defects Orig Artic Ser; 1975; 11(1):579-91. PubMed ID: 125123
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
    Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
    J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional implication for the topographical relationship between MHC class II and the low-affinity IgE receptor: occupancy of CD23 prevents B lymphocytes from stimulating allogeneic mixed lymphocyte responses.
    Flores-Romo L; Johnson GD; Ghaderi AA; Stanworth DR; Veronesi A; Gordon J
    Eur J Immunol; 1990 Nov; 20(11):2465-9. PubMed ID: 2147649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Problems and prospects in surgical immunology II.
    Häyry P
    Med Biol; 1976 Apr; 54(2):73-107. PubMed ID: 131887
    [No Abstract]   [Full Text] [Related]  

  • 18. Significance of HLA-DR matching and of B cell crossmatch tests in vitro and in cadaver renal transplantation.
    Albrechtsen D; Arnesen E; Solheim BG; Thorsby E
    Transplant Proc; 1979 Mar; 11(1):743-7. PubMed ID: 156432
    [No Abstract]   [Full Text] [Related]  

  • 19. HLA and B-lymphocyte alloantigens in Gila River Indians.
    Ensroth AF; Mann DL; Johnson AH; Knowler WC; Pettitt DJ; Bennett PH
    Tissue Antigens; 1983 Mar; 21(3):198-207. PubMed ID: 6407143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MLC and HLA-DR typing: their relationship and relevance for transplantation.
    Cullen PR; Ting A; Morris PJ
    Transplant Proc; 1979 Mar; 11(1):756-9. PubMed ID: 156433
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.